-
Watson seeks approval for generic Type 2 diabetes drug
PARSIPPANY, N.J. — Generic drug maker Watson is challenging the patent protection on a drug used to treat Type 2 diabetes.
Watson said Thursday that it had filed with the Food and Drug Administration for approval of a generic version of Depomed's Glumetza (metformin hydrochloride extended-release tablets) in the 1,000-mg strength.
-
Mark Wahlberg, GNC team on Marked sports nutrition line
PITTSBURGH — GNC on Wednesday announced its partnership with actor/producer Mark Wahlberg on the launch of Marked, a new nutritional supplement line designed to meet the demanding lifestyles of fitness consumers.
"I'm excited to join forces with GNC, a brand I trust for quality and integrity, to develop the Marked products," Wahlberg said. "I attribute much of my own success to my dedication to living healthy and fit, so it is important for me to create products that will help motivate others to pursue their own personal wellness goals."